Welcome to CDC stacks | Defining the Optimal Dose of Rifapentine for Pulmonary Tuberculosis: Exposure-Response Relations From Two Phase 2 Clinical Trials - 47441 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Defining the Optimal Dose of Rifapentine for Pulmonary Tuberculosis: Exposure-Response Relations From Two Phase 2 Clinical Trials
  • Published Date:
    Mar 02 2017
  • Source:
    Clin Pharmacol Ther. 102(2):321-331.
  • Language:
    English
Filetype[PDF-443.01 KB]


Details:
No Related Documents.
You May Also Like: